EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood
- Examine the mutational status of the EGFR pathway in tumor and blood samples from
patients with lung cancer.
- Correlate the EGFR pathway mutations in these samples with clinical outcomes of these
OUTLINE: Archived tumor tissue and blood samples are analyzed via PCR to detect EGFR pathway
mutations in DNA.
Mutational status of the EGFR pathway
Philip C. Mack, PhD
University of California, Davis
|University of California Davis Cancer Center||Sacramento, California 95817|